查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888686

感染疾病診斷劑市場規模、佔有率和趨勢分析報告：按產品、治療領域、技術、最終用途、地區和細分市場預測（2025-2033 年）

Diagnostic Reagents For Infectious Diseases Market Size, Share & Trends Analysis Report By Product, By Disease Area, By Technology, By End Use, By Region, and Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

感染疾病診斷劑市場摘要

2024年全球感染疾病診斷劑市場規模估計為34.7531億美元，預計2033年將達到80.7907億美元。

預計從 2025 年到 2033 年，該市場將以 9.30% 的複合年成長率成長。市場成長的主要驅動力是呼吸系統疾病和性行為感染感染 (STI) 的上升趨勢。

呼吸系統疾病，例如流感、新冠肺炎、肺炎和結核病，在全球發病率最高。根據聯合國兒童基金會2023年的報告，全球每年每10萬名兒童中就有超過1,400例肺炎病例，即每71名兒童中就有1例。 2023年發病率最高的地區是南亞（每10萬名兒童中有2500例）和西非及中非（每10萬名兒童中有1620例）。

此外，根據世界衛生組織估計，全球約有1,080萬人感染結核病，其中男性600萬，女性360萬，其他人口130萬。因此，結核病發病率的上升刺激了對分子診斷和就地檢驗等先進診斷技術的強勁需求，從而推動了市場成長。此外，遠端醫療服務的快速發展和家庭檢測解決方案的廣泛應用也進一步促進了市場擴張。

此外，全球意識的提高和政府支持的篩檢計畫正在促進早期發現和預防工作。 2025年5月出版的《世界衛生日誌》發表了一項關於1996年至2023年感染疾病疫情分佈及其對健康影響的全球評估報告。世界衛生組織（世衛組織）已確定約30種優先病原體，包括猴痘、登革熱和甲型流感病毒，這些病原體有可能引發全球公共衛生緊急事件。這份更新後的清單強調了應對這些高風險感染疾病的重要性，因為它們具有高傳染性、高致病性以及缺乏疫苗或治療方法等特徵。隨著氣候變遷、森林砍伐和都市化進程加快等全球性問題加劇了這些疾病傳播的風險，對感染疾病試劑的需求也不斷成長。

此外，先進分子技術在發展中地區的普及在推動市場成長方面發揮關鍵作用。醫療基礎設施投資的增加以及創新診斷工具取得途徑的改善，使得感染疾病的快速、低成本和高精度檢測成為可能。例如，2024年1月，荷蘭凱傑公司（QIAGEN）在印度推出了QIAstat-Dx儀器的檢測試劑盒和試劑，這些試劑盒和試劑旨在快速準確地診斷感染疾病。這些措施正在加速分子診斷技術在開發中地區的普及，從而顯著促進市場成長。

此外，各國政府加大對病原體基因組監測的投入，推動了分子診斷相關感染疾病試劑的需求。 2024年2月，世界衛生組織宣布捐助者承諾提供400萬美元，設立一項催化津貼基金，支持開展病原體基因組監測的組織。該基金將支持全球範圍內的先導計畫，尤其是在中低收入國家。隨著各實驗室實施這些先導計畫，對分子診斷劑（包括PCR試劑盒、定序試劑和其他耗材）的需求日益成長。檢測能力的提升確保了試劑更頻繁、更常規的使用，從而創造了持續的需求，並增強了全球有效檢測、預防和應對感染疾病疫情的能力。

目錄

第1章感染疾病診斷劑市場：調查方法與範圍

第2章：感染疾病診斷劑市場：執行摘要

  • 市場概覽
  • 產品
  • 疾病領域概述
  • 技術概述
  • 最終用途概述
  • 競爭格局概述

第3章感染疾病診斷劑市場的變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 再次出現的感染疾病增加
    • 分子診斷技術的進展
  • 市場限制因素分析
    • 複雜的檢驗過程
    • 感染疾病診斷劑高成本
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章感染疾病診斷劑市場：按產品分類的估算與趨勢分析

  • 感染疾病診斷劑市場：依產品分類的波動分析
  • 分子試劑
  • 免疫檢測試劑
  • 快速檢測試劑
  • 血清學試劑
  • 控制器和校準器
  • 其他試劑

第5章：感染疾病診斷劑市場：依疾病領域分類的估算與趨勢分析

  • 感染疾病診斷劑市場：依疾病領域分析市場波動
  • 呼吸道感染疾病
  • 性行為感染疾病和熱帶疾病
  • 腸道感染疾病
  • 性行為感染感染（STI）
  • 其他感染疾病/高負擔感染疾病

第6章：感染疾病診斷劑市場：依技術分類的估算與趨勢分析

  • 感染疾病診斷劑市場：波動分析
  • 分子診斷
  • 免疫檢測
  • 照護現場試劑
  • 連接複用平台

第7章感染疾病診斷劑市場：依最終用途分類的估算與趨勢分析

  • 感染疾病診斷劑市場：依最終用途分類的差異分析
  • 醫院和診所
  • 診斷檢查室
  • 即時偵測/分散式檢查設施
  • 公共衛生機構與國家參考實驗室
  • 學術和研究機構

第8章感染疾病診斷劑市場：按地區分類的業務分析

  • 區域市場概覽
  • 北美洲
  • 歐洲
  • 亞太地區

競爭場景

  • 拉丁美洲
    • 2021-2033年拉丁美洲感染疾病診斷劑市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲感染疾病診斷劑市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 合夥
    • 獲得
    • 合資
    • 資金籌措
  • 主要企業市佔率分析（2024 年）
  • 公司熱力圖分析
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • QIAGEN
    • bioMerieux
    • Bio-Rad Laboratories, Inc.
    • Seegene Inc.
    • Thermo Fisher Scientific, Inc.
    • SD Biosensor
    • Mindray
    • Boditech Med Inc.
Product Code: GVR-4-68040-817-0

Diagnostic Reagents For Infectious Diseases Market Summary

The global diagnostic reagents for infectious diseases market size was estimated at USD 3,475.31 millionin 2024 and is projected to reach USD 8,079.07 million by 2033, growing at a CAGR of 9.30% from 2025 to 2033. The market is primarily driven by the increasing prevalence of respiratory diseases and sexually transmitted infections (STIs).

Respiratory diseases, including influenza, COVID-19, pneumonia, and tuberculosis, have the highest prevalence worldwide. The UNICEF 2023 report stated that, every year, there are over 1,400 cases of pneumonia per 100,000 children worldwide, or one case per 71 children, with the highest incidences occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000) in 2023.

Moreover, the WHO estimated 10.8 million people worldwide became ill with tuberculosis, including 6.0 million men, 3.6 million women, and 1.3 million. Therefore, the rising prevalence rate is driving strong demand for advanced diagnostic technologies such as molecular diagnostics and point-of-care testing, fueling market growth. In addition, the rapid expansion of telemedicine services and the growing adoption of home-based testing solutions are further contributing to the market's expansion.

Furthermore, rising global awareness and government-supported screening programs are encouraging early detection and prevention initiatives. The Journal of Global Health reported in May 2025 that the distribution and health impact of infectious disease outbreaks from 1996 to 2023 were globally assessed. The World Health Organization has identified approximately 30 priority pathogens, including monkeypox virus, dengue virus, and influenza A viruses, that could cause global public health emergencies. This updated list emphasizes the significance of focusing efforts on these high-risk infections due to their high transmissibility, virulence, and the scarcity of vaccines and treatment options. As global concerns such as climate change, deforestation, and growing urbanization increase the risk of these illnesses spreading, boosting the demand for infectious disease reagents.

Furthermore, the expansion of advanced molecular technologies in developing regions is playing a crucial role in driving market growth. Growing investments in healthcare infrastructure and increasing access to innovative diagnostic tools are enabling faster, cost-effective, and more accurate detection of infectious diseases. For instance, in January 2024, QIAGEN (Netherlands) launched testing panels for its QIAstat-Dx instruments, along with reagents, in India for rapid and accurate diagnosis of infectious diseases. Such initiatives are accelerating the adoption of molecular diagnostics in developing regions and significantly contributing to market growth.

Moreover, the increasing funding by governments to target pathogen genomic surveillance is boosting the demand for infectious disease reagents associated with molecular diagnostics. In February 2024, the WHO announced that donors had contributed USD 4 million to establish a catalytic grant fund for organizations working in pathogen genomic surveillance. The fund will support pilot projects worldwide, particularly in low- and middle-income countries. As laboratories implement these pilot projects, there is an increased need for molecular diagnostics reagents, including PCR kits, sequencing reagents, and other consumables. This expansion of testing capabilities ensures more frequent and routine use of reagents, creating sustained demand while enhancing global capacity to detect, prevent, and respond effectively to infectious disease outbreaks.

Global Diagnostic Reagents For Infectious Diseases Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global diagnostic reagents for infectious diseases market report based on product, disease area, technology, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Reagents
  • Immunoassay Reagents
  • Rapid Test Reagents
  • Serology Reagents
  • Controls and Calibrators
  • Other Reagents
  • Disease Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory Infections
  • Vector-Borne & Tropical Diseases
  • Enteric Infections
  • Sexually Transmitted Infections (STIs)
  • Other Emerging / High-Burden Infectious Diseases
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Diagnostics
  • Immunoassays
  • Point-of-Care Reagents
  • Multiplex Platforms
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Point-of-Care / Decentralized Testing Sites
  • Public Health Agencies & National Reference Labs
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Diagnostic Reagents for Infectious Diseases Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product
      • 1.1.1.2. Disease Area Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Diagnostic Reagents for Infectious Diseases Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product
  • 2.3. Disease Area Snapshot
  • 2.4. Technology Snapshot
  • 2.5. End Use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Diagnostic Reagents for Infectious Diseases Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increase in re-emerging infectious diseases
    • 3.4.2. Advancements in molecular diagnostics
  • 3.5. Market Restraint Analysis
    • 3.5.1. Complex validation processes
    • 3.5.2. High cost of infectious disease diagnostic reagents
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Diagnostic Reagents for Infectious Diseases Market: Product Estimates & Trend Analysis

  • 4.1. Diagnostic Reagents for Infectious Diseases Market: Product Movement Analysis
  • 4.2. Molecular Reagents
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Immunoassay Reagents
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Rapid Test Reagents
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Serology Reagents
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Controls and Calibrators
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Other Reagents
    • 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Diagnostic Reagents for Infectious Diseases Market: Disease Area Estimates & Trend Analysis

  • 5.1. Diagnostic Reagents for Infectious Diseases Market: Disease Area Movement Analysis
  • 5.2. Respiratory Infections
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Vector-Borne & Tropical Diseases
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Enteric Infections
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Sexually Transmitted Infections (STIs)
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other Emerging / High-Burden Infectious Diseases
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Diagnostic Reagents for Infectious Diseases Market: Technology Estimates & Trend Analysis

  • 6.1. Diagnostic Reagents for Infectious Diseases Market: End Use Movement Analysis
  • 6.2. Molecular Diagnostics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Immunoassays
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Point-of-Care Reagents
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Multiplex Platforms
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Diagnostic Reagents for Infectious Diseases Market: End Use Estimates & Trend Analysis

  • 7.1. Diagnostic Reagents for Infectious Diseases Market: End Use Movement Analysis
  • 7.2. Hospitals & Clinics
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Point-of-Care / Decentralized Testing Sites
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Public Health Agencies & National Reference Labs
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Diagnostic Reagents for Infectious Diseases Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Diagnostic Reagents for Infectious Diseases Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario

. Competitive Scenario

  • 8.5. Latin America
    • 8.5.1. Latin America Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Diagnostic Reagents for Infectious Diseases Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. F. Hoffmann-La Roche Ltd
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Abbott
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. QIAGEN
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. bioMerieux
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Bio-Rad Laboratories, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Seegene Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Thermo Fisher Scientific, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. SD Biosensor
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Mindray
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Boditech Med Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Diagnostic Reagents for Infectious Diseases Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 6 Global Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 11 North America Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 15 U.S. Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 19 Canada Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 23 Mexico Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 28 Europe Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 32 UK Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 UK Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 36 Germany Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 40 France Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 France Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 44 Italy Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 48 Spain Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Sweden Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 52 Sweden Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 53 Sweden Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Norway Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 56 Norway Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 60 Denmark Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 Denmark Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Japan Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 69 Japan Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Japan Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 China Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 73 China Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 China Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 77 India Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 78 India Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 Australia Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 81 Australia Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 82 Australia Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 85 Thailand Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 89 South Korea Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 90 South Korea Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 94 Latin America Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 98 Brazil Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 102 Argentina Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA Diagnostic Reagents for Infectious Diseases Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 MEA Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 MEA Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 107 MEA Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 108 MEA Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 111 South Africa Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 119 UAE Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Diagnostic Reagents for Infectious Diseases Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Diagnostic Reagents for Infectious Diseases Market, By Disease Area, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Diagnostic Reagents for Infectious Diseases Market, By Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Diagnostic Reagents for Infectious Diseases Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global diagnostic reagents for infectious diseases market- Key market driver analysis
  • Fig. 7 Global diagnostic reagents for infectious diseases market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global diagnostic reagents for infectious diseases market - Porter's analysis
  • Fig. 10 Global diagnostic reagents for infectious diseases market - PESTEL analysis
  • Fig. 11 Global diagnostic reagents for infectious diseases market Product outlook key takeaways
  • Fig. 12 Global diagnostic reagents for infectious diseases market: Product movement analysis
  • Fig. 13 Molecular reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Immunoassay reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Rapid test reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Serology reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Controls and calibrators market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Global diagnostic reagents for infectious diseases market Disease area outlook key takeaways
  • Fig. 20 Global diagnostic reagents for infectious diseases market: Disease area movement analysis
  • Fig. 21 Respiratory infections market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Vector-borne & tropical diseases market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Enteric infections market estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Sexually transmitted infections (STIS) market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Other emerging / high-burden infectious diseases market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Global diagnostic reagents for infectious diseases market: Technology outlook key takeaways
  • Fig. 27 Global diagnostic reagents for infectious diseases market: Technology movement analysis
  • Fig. 28 Molecular diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Immunoassays market estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Point-of-care reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Multiplex platforms market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Global diagnostic reagents for infectious diseases market: End Use outlook key takeaways
  • Fig. 33 Global diagnostic reagents for infectious diseases market: End Use movement analysis
  • Fig. 34 Hospitals & clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Diagnostic laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Point-of-care / decentralized testing sites market estimates, 2021 - 2033 (USD Million)
  • Fig. 37 Public health agencies & national reference labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 38 Academic & research institutes market estimates, 2021 - 2033 (USD Million)
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 Global diagnostic reagents for infectious diseases market: Regional movement analysis
  • Fig. 41 North America diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 44 Mexico diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 46 UK diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 47 Germany diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 48 France diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 50 Italy diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 52 Sweden diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 53 Norway diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 55 Japan diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 56 China diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 57 India diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 59 Australia diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 60 Thailand diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 64 MEA diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait diagnostic reagents for infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 69 Strategy framework